Center for Environmental Health et al v. McCarthy et al
Filing
36
ORDER GRANTING 32 DEFENDANTS' MOTION FOR SUMMARY JUDGMENT AND DENYING 30 PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT. Signed by Judge William H. Orrick on 06/29/2016. (jmdS, COURT STAFF) (Filed on 6/29/2016)
1
2
3
4
UNITED STATES DISTRICT COURT
5
NORTHERN DISTRICT OF CALIFORNIA
6
CENTER FOR ENVIRONMENTAL
HEALTH, et al.,
7
Plaintiffs,
8
v.
9
10
GINA MCCARTHY, et al.,
ORDER GRANTING DEFENDANTS'
MOTION FOR SUMMARY JUDGMENT
AND DENYING PLAINTIFFS' MOTION
FOR SUMMARY JUDGMENT
Re: Dkt. Nos. 30, 32
Defendants.
11
United States District Court
Northern District of California
Case No. 15-cv-02939-WHO
12
INTRODUCTION
13
The Federal Insecticide, Fungicide, and Rodenticide Act, under which the Environmental
14
Protection Agency can regulate pesticides, requires that active ingredients be disclosed on
15
pesticide labels. Inert ingredients are not subject to the same requirements. For a decade plaintiffs
16
Center for Environmental Health, Beyond Pesticides and Physicians for Social Responsibility
17
have urged defendants Environmental Protection Agency and its Administrator1, (collectively
18
“EPA”), to require the disclosure of 371 inert ingredients on the labels of pesticide products. They
19
previously filed an initial rulemaking petition and two related lawsuits and now challenge the
20
EPA’s May 2014 decision that effectively denied their petition. Both sides have moved for
21
summary judgment.
22
The plaintiffs are understandably frustrated that the rulemaking process they initiated
23
almost ten years ago has generated no concrete action. They may well be on the right side of the
24
policy argument. But the EPA is not mandated to require disclosure of the inert ingredients at
25
issue. Its decision to pursue non-rulemaking alternatives to address the issue is not arbitrary or
26
capricious. As a result, I must GRANT the EPA’s motion for summary judgment and DENY
27
28
1
Now Gina McCarthy.
1
plaintiffs’ motion for summary judgment.
BACKGROUND
2
3
In August 2006, a coalition of numerous states and public health organizations, including
4
plaintiffs, petitioned the EPA to initiate rulemaking to require the labeling of 371 inert ingredients
5
on pesticides. Three years later plaintiffs filed a lawsuit against the EPA because it had not acted
6
on the petition. Ctr. for Envt’l Health Californians for Pesticide Reform v. United States
7
Environmental Protection Agency, et al., No. 09-cv-02868-PJH (N.D. Cal. June 26, 2009), Dkt.
8
No. 1. They alleged that the EPA’s unreasonable delay in acting on the petition violated the
9
Administrative Procedure Act. The EPA issued a response in September 2009, stating that it
would be “initiating rulemaking to increase the public availability of hazardous inert ingredient
11
United States District Court
Northern District of California
10
identities for specific pesticide formulations” but that it was “not committing [] to any particular
12
outcome for rulemaking.” AR 2788.2 Plaintiffs then voluntarily dismissed their claims.
13
The EPA initiated its rulemaking via an Advance Notice of Proposed Rulemaking
14
(“ANPR”) published in the Federal Register on December 23, 2009. 74 Fed. Reg. 68, 215. The
15
EPA solicited comments on two alternative proposals – one that would have required listing only
16
“potentially hazardous” inert ingredients and another that would have required listing most or all
17
inert ingredients, regardless of hazard. 74 Fed. Reg. 68, 219-22. In response, the EPA received
18
405 comments from the public. However, no rule was issued as a result.
19
In March 2014, plaintiffs filed a second lawsuit asserting that the EPA had not taken
20
further action to follow through on its commitment to adopt a rule since it had published the
21
ANPR in December 2009. Ctr. for Envt’l Health v. McCarthy, No. 14-cv-01013-WHO (N.D. Cal.
22
March 5, 2014), Dkt. No. 1. Plaintiffs once again alleged that the EPA’s delay in completing the
23
rulemaking process or otherwise concluding the action violated the Administrative Procedure Act.
24
A little over two months later, on May 22, 2014, the EPA amended its 2009 response to plaintiffs’
25
2006 petition. The EPA’s amended response explained that “the EPA has now decided not to
26
pursue finalization of the rulemaking it initiated seeking to mandate the disclosure on the label of a
27
28
2
All “AR” cites are to the administrative record in this case.
2
1
pesticide of the presence of a hazardous inert ingredient.” AR2875. Instead it stated that it had
2
“re-evaluated” how to best address potentially hazardous inert ingredients and believed a different
3
approach was more appropriate. AR2877. In the letter, the EPA asserted it would “review inert
4
ingredients currently listed for use in pesticides, update that list, establish criteria for prioritization,
5
and select top candidate inert ingredients for further analysis and potential action.” Id.
6
The EPA thereafter moved for judgment on the pleadings in the 2014 lawsuit. Because the
7
EPA had acted on plaintiffs’ underlying petitions, I granted the motion, finding that there was no
8
further relief that I could offer to the plaintiffs and that the action was moot. Ctr. for Envt’l Health
9
v. McCarthy, No. 14-cv-01013-WHO, (N.D. Cal. Sept. 15, 2014), Dkt. No. 31.
10
Plaintiffs’ instant lawsuit challenges the EPA’s May 2014 denial of their rulemaking
United States District Court
Northern District of California
11
petition. Their complaint alleges a sole cause of action under the Federal Insecticide, Fungicide,
12
and Rodenticide Act and the Administrative Procedure Act. Plaintiffs seek, among other relief, to
13
set aside the denial and to remand the decision to the EPA to consider “the evidence weighing in
14
favor of disclosure of inert pesticides ingredients.” Compl. at 14 [Dkt. No. 1]. They move for
15
summary judgment, arguing that the EPA’s decision to deny plaintiffs’ rulemaking petition was
16
arbitrary, capricious, and contrary to the Federal Insecticide, Fungicide, and Rodenticide Act. The
17
EPA oppose and cross-move for summary judgment, asserting that its decision was reasonable and
18
should be upheld. I held a hearing on June 8, 2016.
19
LEGAL STANDARD
20
When a district court reviews an administrative agency’s decision, pursuant to the
21
Administrative Procedures Act, “summary judgment is an appropriate mechanism for deciding the
22
legal question of whether the agency could reasonably have found the facts as it did.” Occidental
23
Eng’g Co. v. I.N.S., 753 F.2d 766, 770 (9th Cir.1985). The court does not resolve any issues of
24
disputed facts. Id. at 769. Instead, the court must uphold an agency decision unless it is found to
25
be “arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with law,” or
26
“without observance of procedure required by law.” 5 U.S.C. § 706(2). This is a “deferential
27
standard... designed to ensure that the agency considered all of the relevant factors and that its
28
decision contained no clear error of judgment.” Pac. Coast Fed’n of Fishermen’s Ass’n v. Nat’l
3
1
Marine Fisheries Serv., 265 F.3d 1028, 1034 (9th Cir. 2001). An agency action should be
2
overturned only when the agency has “relied on factors which Congress has not intended it to
3
consider, entirely failed to consider an important aspect of the problem, offered an explanation for
4
its decision that runs counter to the evidence before the agency, or is so implausible that it could
5
not be ascribed to a difference in view or the product of agency expertise.” Id.
DISCUSSION
6
7
I.
DISCLOSURE REQUIREMENTS
8
Plaintiffs assert that the 371 inert ingredients identified in their petition have been
9
designated by the EPA or the Occupation Safety and Health Administration (“OSHA”) as
hazardous under one or more federal statutes, including the Clean Air Act, 42 U.S.C. § 7401, the
11
United States District Court
Northern District of California
10
Clean Water Act, 33 U.S.C. § 1251, and the Emergency Planning and Community Right to Know
12
Act, 42 U.S.C. § 11001. As a result of these designations, plaintiffs insist that certain subsections
13
of the Federal Insecticide, Fungicide, and Rodenticide Act (“FIFRA”) and related regulations
14
mandate that the EPA require disclosure of these chemicals on pesticide products.
15
Under FIFRA, the EPA is required to “determin[e] the risks which may be posed by a
16
pesticide and impos[e] the necessary regulatory requirement to adequately control an unreasonable
17
risk.” 40 Fed. Reg. 28,252. Generally, before allowing the registration of a pesticide, the EPA
18
must determine, among other things, that the pesticide “will not generally cause unreasonable
19
adverse effects on the environment.” 7 U.S.C. § 136a(c)(5)(d). The statute defines “unreasonable
20
adverse effects” to mean: (1) “any unreasonable risk to man or the environment, taking into
21
account the economic, social, and environmental costs and benefits of the use of any pesticide,” or
22
(2) “a human dietary risk from residues that result from a use of a pesticide in or on any food”
23
inconsistent with the standard under section 408 of the Federal Food, Drug, and Cosmetic Act. 7
24
U.S.C. § 136(bb). Depending on the risk involved, the agency is authorized to deny a product’s
25
registration, classify the pesticide for restricted use, or require specific label statements. 40 Fed.
26
Reg. 28,252. While the regulations provide that the EPA may require the listing of inert
27
ingredients on a product’s label, this power “does not affect [the EPA’s] authority to take other
28
regulatory action if the label statement does not protect against the hazard.” Id. Section
4
1
10(d)(1)(C) of FIFRA provides that FIFRA “does not authorize the disclosure of any information
2
that . . . discloses the identity or percentage quantity of any deliberately added inert ingredient of
3
a pesticide” unless the EPA has first “determined that disclosure is necessary to protect against an
4
unreasonable risk of injury to health or the environment.” 7 U.S.C. § 136h(d)(1)(C) (“This
5
paragraph does not authorize the disclosure of any information that: . . . (c) discloses the identity
6
or percentage quantity of any deliberately added inert ingredient of a pesticide, unless the
7
Administrator has first determined that disclosure is necessary to protect against an unreasonable
8
risk of injury to health or the environment.”).
The parties disagree over whether the hazard designations that plaintiffs identify constitute
10
the basis for a finding of “unreasonable risk” under FIFRA. Plaintiffs assert, for example, that the
11
United States District Court
Northern District of California
9
EPA’s decisions to label seventy-nine of the ingredients at issue as hazardous for the purposes of
12
the Clean Water Act are the functional equivalent of an “unreasonable risk” determination under
13
FIFRA. The EPA responds that an unreasonable risk finding under FIFRA is distinct from any
14
previous determination. But assuming that plaintiffs are correct, the EPA still is not obligated to
15
address the risk through mandatory label disclosure. Contrary to plaintiffs’ arguments, section
16
10(d)(1)(C) does not require EPA to disclose any inert ingredients, but simply authorizes it to do
17
so after the agency has made the requisite preliminary determination. See 7 U.S.C. §
18
136h(d)(1)(C).
19
In support of its position that the EPA must act once it makes a hazard determination,
20
plaintiffs rely heavily on Massachusetts v. E.P.A., 549 U.S. 497 (2007). In Massachusetts, the
21
Supreme Court reviewed the EPA’s denial of a rulemaking petition requesting that the agency
22
regulate greenhouse gas emissions from motor vehicles under the Clean Air Act. 549 U.S. at 510.
23
The EPA had denied the petition on two grounds: (1) the Clean Air Act did not authorize it to
24
issue regulations concerning climate change, and (2) even if it did, it would have been “unwise” to
25
do so because of various policy considerations. Id. at 511.
26
The Clean Air Act provides that the EPA “shall by regulation prescribe . . . standards
27
applicable to the emission of any new air pollutant from any class or classes of new motor vehicles
28
or new motor vehicle engines, which in [the EPA’s] judgment cause, or contribute to, air pollution
5
1
which may reasonably be anticipated to endanger public health or welfare.” Id. at 506 (emphasis
2
added). Based in part on this language, the Court concluded that the EPA had the requisite
3
statutory authority to regulate greenhouse gasses under the Clean Air Act and that the EPA had
4
offered “no reasoned explanation for its refusal to decide whether greenhouse gases cause or
5
contribute to climate change.” Id. at 534.
6
Plaintiffs argue that because the Court in Massachusetts used the term “authorize” to
7
describe the EPA’s power under the Clean Air Act, I should also find that EPA has a requirement
8
to act in this case. But Massachusetts does not stand for the proposition that because the EPA is
9
authorized to act in accordance with the requested rulemaking, it is obligated to do so. In
Massachusetts, the EPA argued that it lacked authority under section 202(a)(1) of the Clean Air
11
United States District Court
Northern District of California
10
Act to regulate new vehicle emissions because carbon dioxide is not an “air pollutant” as defined
12
by the Act. Id. at 528. The Court determined that because “greenhouse gases fit well within the
13
Clean Air Act’s capacious definition of ‘air pollutant,’ we hold that the EPA has the statutory
14
authority to regulate the emission of such gases.” Id. at 532. But the Court did not stop there. It
15
went on to hold that, pursuant to the statutory language, if the “EPA makes a finding of
16
endangerment, the Clean Air requires the Agency to regulate emission of the deleterious pollutant
17
from new motor vehicles.” Id. (quoting a section of the statute stating that the EPA “shall by
18
regulation prescribe…standards applicable to the emission of any air pollutant”) (emphasis added).
19
Here, section 10(d)(1)(C) of FIFRA does not use the word “shall” or any similar
20
mandatory language. The statute’s use of the term “authorize” does not convert it to the “clear
21
statutory command” at issue in Massachusetts. Id. at 533. As a result, plaintiffs’ argument that
22
this section of FIFRA mandates that the EPA disclose the 371 inert ingredients is unconvincing.
23
Similarly, plaintiffs’ characterization of 40 C.F.R. § 156.10(g)(7) as establishing the
24
criteria which, if met, require disclosure, is inaccurate. This regulation provides that “[t]he
25
Administrator may require the name of any inert ingredient(s) to be listed in the ingredient
26
statement if he determines that such ingredient(s) may pose a hazard to man or the environment.”
27
40 C.F.R. § 156.10(g)(7) (emphasis added). While this permits EPA to require the listing of
28
hazardous inert ingredients, it does not mandate it.
6
1
Plaintiffs’ also argue that the EPA has discarded its previous factual findings without a
2
reasoned explanation in violation of the Ninth Circuit’s ruling in Organized Village of Kake v.
3
U.S. Department of Agriculture, 795 F.3d 956 (9th Cir. 2015). At issue in Kake was a 2001
4
decision by the United States Department of Agriculture to promulgate a “roadless rule,” limiting
5
road construction and timber harvesting in national forests, and to apply it to the Tongass National
6
Forest. 795 F.3d at 959. Two years after it made this decision, the Department of Agriculture,
7
relying on the identical factual record compiled in 2001, reversed its course, finding that the
8
application of the roadless rule to the Tongass National Forest was unnecessary. Id. In deciding
9
whether this change was justified, the Ninth Circuit explained that a policy change complies with
the Administrative Procedure Act if the agency: (1) “displays awareness that it is changing
11
United States District Court
Northern District of California
10
position,” (2) “shows that the new policy is permissible under the statute,” (3) “believes the new
12
policy is better,” and (4) “provides good reasons for the new policy, which, if the new policy rests
13
upon factual findings that contradict those which underlay its prior policy, must include a reasoned
14
explanation . . . for disregarding facts and circumstances that underlay or were engendered by the
15
prior policy.” Id. at 966 (internal quotation marks omitted). In Kake, the court concluded that the
16
Department of Agriculture had not provided a good reason to disregard the factual findings that
17
governed its prior decision. Id. at 968. In so holding, the court stated that “[a]n agency cannot
18
simply disregard contrary or inconvenient factual determinations that it made in the past, any more
19
than it can ignore inconvenient facts when it writes on a blank slate.” Id. at 969.
20
Here, the EPA has not made any contradictory determinations. Plaintiffs insist that the
21
EPA’s decision to forego rulemaking after previously recognizing its authority to require
22
disclosure of inert ingredients in the ANPR makes this case analogous to Kake. But the EPA is
23
not negating its authority to require disclosure in certain situations. The EPA’s position is that the
24
hazard determinations on which plaintiffs rely are not akin to an “unreasonable risk” finding under
25
FIFRA and, even if they were, it is not mandated to require label disclosure. Nothing in the
26
ANPR contradicts this position. The ANPR explains that “[t]here is no statutory requirements that
27
the names of all inert ingredients be contained on the ingredients statement.” AR0003. “In some
28
cases, however, EPA has determined that in order to meet the requirements of FIFRA certain inert
7
1
ingredients identities must be disclosed on the labels of products in which they are present.” Id.
2
This statement is followed up with a review of 40 C.F.R. 156.10(g)(7), which as discussed above,
3
provides that the EPA may require disclosure of inert ingredients if the ingredients pose a hazard
4
to man or the environment. Id. This is not a declaration that disclosure of the 371 inert
5
ingredients is necessary. Plaintiffs have provided no persuasive evidence that the EPA’s decision
6
to forego rulemaking is inconsistent with the ANPR.
7
II.
Considering that plaintiffs have not identified any mandatory duty to act, I now turn to
8
9
THE MAY 2014 DECISION
whether the EPA’s decision to deny the plaintiffs’ rulemaking petition and instead to pursue an
alternative path is arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with
11
United States District Court
Northern District of California
10
law. I find that it is not.
A decision is arbitrary and capricious within the meaning of the Administrative Procedure
12
13
Act when the agency has relied on “factors which Congress has not intended it to consider,
14
entirely failed to consider an important aspect of the problem, offered an explanation for its
15
decision that runs counter to the evidence before the agency, or is so implausible that it could not
16
be ascribed to a difference in view of the product of agency expertise.” Beno v. Shalala, 30 F.3d
17
1057, 1073 (9th Cir. 1994) (citation and quotation marks omitted). A court is not empowered to
18
substitute its judgment for that of an agency. Arizona Cattle Growers’ Ass’n v. U.S. Fish &
19
Wildlife, Bureau of Land Mgmt., 273 F.3d 1229, 1236 (9th Cir. 2001). A court should “overturn
20
an agency’s decision not to initiate a rulemaking only for compelling cause, such as plain error of
21
law or a fundamental change in the factual premises previous considered by the agency.” Nat’l
22
Customs Brokers & Forwarders Ass’n of Am., Inc. v. United States, 883 F.2d 93, 97 (D.C. Cir.
23
1989).
24
The EPA’s decision not to pursue rulemaking to mandate label disclosure of inert
25
ingredients is grounded in the statutory text and supported by valid reasoning. As described
26
above, FIFRA grants the EPA discretionary authority to determine how to best manage and
27
address any inert ingredients that may cause unreasonable adverse effects on the environment. No
28
one particular course of action is prescribed. See 40 Fed. Reg. 28,252 (“Depending on the risk
8
1
involved, the agency is authorized to deny a product’s registration, classify the pesticide for
2
restricted use, or require specific label statements.”). In its May 2014 letter to petitioners, the EPA
3
announced that it would pursue a “combination of regulatory and focused non-regulatory actions
4
that do not rely on rulemaking” including potentially: (1) removing over ninety chemicals from
5
the list of inert ingredients approved for pesticide use; (2) evaluating the effect of the 371 inert
6
ingredients on food crops; (3) directing pesticide registrants to modify their registrations by
7
replacing hazardous inert ingredients with less hazardous ones; and (4) seeking to expand the
8
existing voluntary disclosure program. AR2877-79.
9
In support of its decision, the EPA explained that the 405 comments it received in response
to the ANPR were “general in nature, either advocating for or against mandatory disclosure of
11
United States District Court
Northern District of California
10
inert ingredients of pesticides, or offering only broad, general reasons articulating their positions.”
12
AR2875. The comments also revealed “considerable disagreement among various sectors of the
13
public regarding the appropriateness and even legality of the possible requirements discussed in
14
the [ANPR].” Id. Based “in part” on the comments, the EPA decided that pursuing the
15
rulemaking initiated by the ANPR would be “very complex, lengthy and resource intensive.” Id.
16
Plaintiffs refute the EPA’s characterization of the comments, arguing instead that many of
17
the commenters provided pointed remarks that were directed specifically at the proposals. Even
18
so, the nature of the comments was not the sole reason why the EPA decided to change its course.
19
The letter states that, based on information that the EPA had gathered over the past ten years
20
through surveys and focus groups, the EPA had come to the conclusion that most consumers
21
quickly read only a minimal amount of information on pesticide labels when making a purchase.
22
AR2875. “These findings suggest most consumers will not pay attention to information on
23
product labels disclosing the identity of inert ingredients.” Id. This led the EPA to question the
24
extent to which a sizeable percentage of pesticide users and purchasers would change their
25
behavior based on disclosure of inert ingredients in pesticides. While plaintiffs may disagree with
26
how impactful disclosure may be, an agency’s decision on policy matters is given considerable
27
deference. See Prof’l Drivers Council v. Bureau of Motor Carrier Safety, 706 F.2d 1216, 1221
28
(D.C. Cir. 1983) (“[R]ulemaking is an inherently policy-oriented process and the agency must be
9
1
accorded considerable deference in evaluating information presented and reaching decisions based
2
upon its expertise.”); Massachusetts, 549 U.S. at 533 (acknowledging that the courts have “neither
3
the expertise nor the authority” to evaluate an agency’s policy judgments).
4
It was also appropriate for the EPA to consider its limited resources when determining how
5
best to proceed. See Massachusetts, 549 U.S. at 527 (“An agency has broad discretion to choose
6
how to best marshal its limited resources and personnel to carry out its delegated
7
responsibilities.”). The letter described the agency’s “restricted financial and staff resources” and
8
explained that “[m]erely drafting the required portions of a complex rule consumes significant
9
staff resources.” AR 2876-77. Therefore, rulemaking would have been a decidedly long-term
10
project.
United States District Court
Northern District of California
11
Considering these limitations and the reasoning described above, the EPA ultimately
12
decided that a series of non-rule actions would achieve a greater reduction in the risks from the use
13
of pesticides and could be implemented in a timelier manner. AR2877. This decision conceivably
14
offers a less effective remedy than what plaintiffs sought, but it is not arbitrary, capricious, or
15
contrary to the relevant law.
CONCLUSION
16
17
For the reasons described above, the EPA’s motion for summary judgment is GRANTED
18
and plaintiffs’ motion for summary judgment is DENIED. Judgment shall be entered in
19
accordance with this Order.
20
21
22
23
IT IS SO ORDERED.
Dated: June 29, 2016
______________________________________
WILLIAM H. ORRICK
United States District Judge
24
25
26
27
28
10
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?